2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin,
2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride,
2-(N-propyl-N-phenethylamino)-5-hydroxytetralin,
N 0434,
N 434,
N-0434,
(+/-)-PPHT hydrochloride,
71787-90-1,
N-0434,
PPHT hydrochloride,
(y)-PPHT hydrochloride,
(?)-PPHT hydrochloride,
EU-0101006,
MLS000860001,
CHEMBL1256754,
CTK8G7698,
DTXSID30474699,
Tox21_501006,
MFCD00055157,
AKOS024418760,
CCG-222310,
LP01006,
MCULE-3742110977,
NCGC00094300-01,
NCGC00261691-01,
SMR000326860,
NCG-C00094300-01,
( inverted question mark)-PPHT hydrochloride,
FT-0757152,
P-105,
( inverted exclamation markA)-PPHT hydrochloride,
SR-01000075394,
SR-01000075394-1,
(+/-)-PPHT hydrochloride, >=98% (HPLC), solid,
(+/-)-PPHT HYDROCHLORIDE (N-0434) POTENTD2 DOPAMINE RE,
(+/-)-2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride,
6-(Phenethyl(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride,
( inverted exclamation markA)-2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride,
( inverted question mark)-2-(N-Phenylethyl)-N-propyl)amino-5-hydroxytetralin hydrochloride,
CID11957671,
N 0434,
1-Naphthalenol, 5,6,7,8-tetrahydro-6-[(2-phenylethyl)propylamino]-, hydrochloride,
87857-27-0,